These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 29581938)

  • 1. Prevalence of Drug-Resistant Tuberculosis in HIV-Positive and Diabetic Patients in Sinaloa, Mexico: A Retrospective Cross-Sectional Study.
    Aispuro Pérez A; Osuna-Martínez U; Espinoza-Gallardo JA; Dorantes-Álvarez LA; Inzunza-Leyva GK; Dorantes-Bernal KE; Quiñonez-Bastidas GN
    Trop Med Infect Dis; 2024 Apr; 9(4):. PubMed ID: 38668550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important co-morbidity in patients with diabetes mellitus in three clinics in Western Kenya.
    Kirui NK; Pastakia SD; Kamano JH; Cheng S; Manuthu E; Chege P; Gardner A; Mwangi A; Enarson DA; Reid AJ; Carter EJ
    Public Health Action; 2012 Dec; 2(4):148-51. PubMed ID: 26392975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability of a national programme for drug-resistant TB: why does a well-designed programme stagnate?
    Shibanuma A
    Public Health Action; 2020 Dec; 10(4):133. PubMed ID: 33437677
    [No Abstract]   [Full Text] [Related]  

  • 4. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era.
    Floyd K; Glaziou P; Zumla A; Raviglione M
    Lancet Respir Med; 2018 Apr; 6(4):299-314. PubMed ID: 29595511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response.
    Perumal R; Naidoo K; Padayatchi N
    BMC Public Health; 2018 Mar; 18(1):417. PubMed ID: 29587706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis.
    Xu G; Hu X; Lian Y; Li X
    BMC Infect Dis; 2023 Nov; 23(1):813. PubMed ID: 37986146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid evidence assessment exploring whether antimicrobial resistance complicates non-infectious health conditions and healthcare services, 2010-20.
    Hocking L; Ali GC; d'Angelo C; Deshpande A; Stevenson C; Virdee M; Guthrie S
    JAC Antimicrob Resist; 2021 Dec; 3(4):dlab171. PubMed ID: 34806009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of drug resistant tuberculosis patients with multiple poor prognostic indicators in Uganda: A countrywide 5-year retrospective study.
    Baluku JB; Nakazibwe B; Naloka J; Nabwana M; Mwanja S; Mulwana R; Sempiira M; Nassozi S; Babirye F; Namugenyi C; Ntambi S; Namiiro S; Bongomin F; Katuramu R; Andia-Biraro I; Worodria W
    J Clin Tuberc Other Mycobact Dis; 2021 May; 23():100221. PubMed ID: 33553682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis.
    Gautam S; Shrestha N; Mahato S; Nguyen TPA; Mishra SR; Berg-Beckhoff G
    Sci Rep; 2021 Jan; 11(1):2113. PubMed ID: 33483542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and adverse events of pre- and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: A retrospective cohort study.
    Kashongwe IM; Mawete F; Mbulula L; Nsuela DJ; Losenga L; Anshambi N; Aloni M; Kaswa M; Kayembe JMN; Umba P; Lepira FB; Kashongwe ZM
    PLoS One; 2020; 15(8):e0236264. PubMed ID: 32750060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Mellitus among new tuberculosis patients in Bamako, Mali.
    Diarra B; Tolofoudie M; Sarro YS; Togo ACG; Bane S; Nientao I; Cisse AB; Kone M; Somboro A; Degoga B; Diallo F; Coulibaly G; Kodio O; Sanogo M; Kone B; Diabate S; Baya B; Kone A; Dabitao D; Maiga M; Belson M; Dao S; Maiga II; Murphy RL; Siddiqui S; Toloba Y; Konate B; Doumbia S; de Jong BC; Diallo S
    J Clin Tuberc Other Mycobact Dis; 2019 Dec; 17():100128. PubMed ID: 31788570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
    Muñoz-Torrico M; Caminero-Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Vergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Arch Bronconeumol; 2017 May; 53(5):245-250. PubMed ID: 28089216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do patients with DR-TB do not complete their treatment? Findings of a qualitative study from Pakistan.
    Abubakar M; Ullah M; Shaheen MA; Abdullah O
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.
    Swaminathan A; du Cros P; Seddon JA; Mirgayosieva S; Asladdin R; Dusmatova Z
    BMC Infect Dis; 2017 Jun; 17(1):417. PubMed ID: 28606115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Did diabetes mellitus affect treatment outcome in drug-resistant tuberculosis patients in Pakistan from 2010 to 2014?
    Latif A; Ghafoor A; Wali A; Fatima R; Ul-Haq M; Yaqoob A; Abdullah Z; Najmi H; Khan NM
    Public Health Action; 2018 Mar; 8(1):14-19. PubMed ID: 29581938
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance patterns, treatment outcomes and factors affecting unfavourable treatment outcomes among extensively drug resistant tuberculosis patients in Pakistan; a multicentre record review.
    Atif M; Mukhtar S; Sarwar S; Naseem M; Malik I; Mushtaq A
    Saudi Pharm J; 2022 Apr; 30(4):462-469. PubMed ID: 35527826
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.